RDY FY 2014 Earnings Report — Dr. Reddy's Laboratories Limited Revenue & Financial Results | Market Cap Arena

Dr. Reddy's Laboratories LimitedRDY

FY 2014 Earnings

Reported June 26, 2014

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2014	Prior Q	FY 2013	QoQ Change	YoY Change
Revenue	$1.4B	—	$1.2B	—	13.7%
Op. Income	$276M	—	$224M	—	23.3%
Gross Margin	57.4%	—	52.1%	—	5.2pp
Net Margin	16.3%	—	14.4%	—	1.8pp
EPS (Diluted)	$1.34	—	$1.04	—	28.0%
Free Cash Flow	$94M	—	$63M	—	47.7%

Revenue Flow

Item	Amount
REVENUE	$1.4B
Cost of Revenue	$598M
GROSS PROFIT	$804M
R&D Expenses	$132M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$411M
Other Expenses	-$14M
Operating Expenses	$528M
Cost & Expenses	$1.1B
OPERATING INCOME	$276M
Interest Income	$12M
Interest Expense	$14M
Other Income/Expenses	$6M
INCOME BEFORE TAX	$282M
Income Tax Expense	$54M
Net Income from Continuing Ops	$228M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$228M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$228M
D&A	$75M
EBIT	$296M
EBITDA	$351M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$1.4B
Cost of Revenue	$598M
GROSS PROFIT	$804M
R&D Expenses	$132M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$411M
Other Expenses	-$14M
Operating Expenses	$528M
Cost & Expenses	$1.1B
OPERATING INCOME	$276M
Interest Income	$12M
Interest Expense	$14M
Other Income/Expenses	$6M
INCOME BEFORE TAX	$282M
Income Tax Expense	$54M
Net Income from Continuing Ops	$228M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$228M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$228M
D&A	$75M
EBIT	$296M
EBITDA	$351M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$228M
Depreciation & Amortization	$75M
Stock-Based Compensation	$5M
Deferred Income Tax	$54M
Other Non-Cash Items	-$46M
Change in Working Capital	-$110M
OPERATING CASH FLOW	$206M
Capital Expenditure	-$113M
Acquisitions (Net)	$6M
Purchases of Investments	-$475M
Sales/Maturities of Investments	$400M
Other Investing Activities	$6M
NET CASH FROM INVESTING	-$176M
Net Debt Issuance	$42M
Common Stock Repurchased	$0
Common Dividends Paid	-$32M
Other Financing Activities	-$13M
NET CASH FROM FINANCING	-$2M
FREE CASH FLOW	$94M
Net Change in Cash	$36M

Balance Sheet

Item	Amount
Cash & Equivalents	$356M
Short-Term Investments	$0
Net Receivables	$435M
Inventory	$254M
Other Current Assets	$134M
TOTAL CURRENT ASSETS	$1.1B
PP&E (Net)	$471M
Goodwill	$36M
Intangible Assets	$120M
Long-Term Investments	$9M
Tax Assets	$64M
Other Non-Current Assets	$5M
TOTAL NON-CURRENT ASSETS	$705M
TOTAL ASSETS	$1.8B
Account Payables	$0
Short-Term Debt	$254M
Deferred Revenue	$7M
Other Current Liabilities	$85M
TOTAL CURRENT LIABILITIES	$573M
Long-Term Debt	$210M
Deferred Revenue NC	$10M
Deferred Tax Liabilities	$29M
Other Non-Current Liabilities	$49M
TOTAL NON-CURRENT LIABILITIES	$269M
TOTAL LIABILITIES	$842M
Common Stock	$9M
Additional Paid-In Capital	$229M
Retained Earnings	$690M
Treasury Stock	$0
Accum. Other Comp. Income	$35M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$963M
Minority Interest	$0
TOTAL EQUITY	$963M
TOTAL LIABILITIES & EQUITY	$1.8B
Total Debt	$475M
Net Debt	$119M